{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:13:44Z","timestamp":1793384024722,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","award":["2-D3X513"],"award-info":[{"award-number":["2-D3X513"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013121","name":"Sydney West Translational Cancer Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007811","name":"Sydney Medical School Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["632630"],"award-info":[{"award-number":["632630"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1049857"],"award-info":[{"award-number":["1049857"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1053206"],"award-info":[{"award-number":["1053206"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jhep.2019.04.014","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T22:31:59Z","timestamp":1557441119000},"page":"281-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4130-1358","authenticated-orcid":false,"given":"Maryam","family":"Alavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-2017","authenticated-orcid":false,"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-2028","authenticated-orcid":false,"given":"Behzad","family":"Hajarizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Selvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.04.014_b0005","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/cid\/civ197","article-title":"Hepatitis C virus therapeutic development: in pursuit of \u201cperfectovir\u201d","volume":"60","author":"Dore","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2019.04.014_b0010","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021 2016 [June 2018]. Available from: www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/."},{"key":"10.1016\/j.jhep.2019.04.014_b0015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral Direct-acting agent therapy for hepatitis c virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.04.014_b0020","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2019.04.014_b0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.04.014_b0030","article-title":"Direct-acting antivirals for chronic hepatitis C","volume":"9","author":"Jakobsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2019.04.014_b0035","article-title":"Do direct acting antivirals cure chronic hepatitis C?","volume":"361","author":"Jakobsen","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2019.04.014_b0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0140-6736(17)31762-2","article-title":"What is the impact of treatment for hepatitis C virus infection?","volume":"390","author":"Wiktor","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.04.014_b0045","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/cid\/cix620","article-title":"IDSA\/AASLD response to Cochrane review on direct-acting antivirals for hepatitis C","volume":"65","author":"Powderly","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2019.04.014_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ajg.2017.420","article-title":"The Cochrane review conclusion for hepatitis C DAA therapies is wrong","volume":"113","author":"Kwo","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.04.014_b0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2018.02.006","article-title":"Elimination of hepatitis C virus in Australia: laying the foundation","volume":"32","author":"Dore","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhep.2019.04.014_b0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2007.05.026","article-title":"Modelling the hepatitis C virus epidemic in Australia","volume":"91","author":"Razali","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jhep.2019.04.014_b0065","unstructured":"The Centre for Health Record Linkage (CHeReL) [Available from: http:\/\/www.cherel.org.au\/."},{"key":"10.1016\/j.jhep.2019.04.014_b0070","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)69374-4","article-title":"Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study","volume":"368","author":"Amin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.04.014_b0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jhep.2019.04.014_b0080","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jvh.12852","article-title":"Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia","volume":"25","author":"Hajarizadeh","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2019.04.014_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMcp1204714","article-title":"Alcohol use in adults","volume":"368","author":"Friedmann","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.04.014_b0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/jgh.13453","article-title":"Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment","volume":"32","author":"Hajarizadeh","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.04.014_b0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1186\/s12889-016-3732-3","article-title":"Trend in alcohol use in Australia over 13 years: has there been a trend reversal?","volume":"16","author":"Chan","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhep.2019.04.014_b0100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.15288\/jsad.2017.78.844","article-title":"Changing attitudes to alcohol in Australia","volume":"78","author":"Livingston","year":"2017","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.jhep.2019.04.014_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jgh.12677","article-title":"Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia","volume":"29","author":"Sievert","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.04.014_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jvh.13013","article-title":"Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modelling study","volume":"26","author":"Kwon","year":"2019","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.jhep.2019.04.014_b0115","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.04.014_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.29419","article-title":"The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: a population cohort-study","volume":"67","author":"Innes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.04.014_b0125","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.28923","article-title":"Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy","volume":"65","author":"Flemming","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.04.014_b0130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","article-title":"Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study","volume":"65","author":"Belli","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.04.014_b0135","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.07.008","article-title":"Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016","author":"Kim","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.04.014_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201120","article-title":"Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study","volume":"13","author":"Lapointe-Shaw","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.04.014_b0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jhep.2016.06.025","article-title":"Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study","volume":"65","author":"Alavi","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.04.014_b0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1472-6963-12-18","article-title":"Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Health Serv. Res"},{"key":"10.1016\/j.jhep.2019.04.014_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103690","article-title":"A new method for assessing how sensitivity and specificity of linkage studies affects estimation","volume":"9","author":"Moore","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819302752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819302752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:54:14Z","timestamp":1777510454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819302752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0168827819302752"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.04.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}